Showing results (1-10 of 54) with videos related to
Sort By:
Pageof 6
Cancer Science|April 17, 2018
Molecular biomarkers for uterine leiomyosarcoma and endometrial stromal sarcomaHideaki Tsuyoshi, Yoshio YoshidaThe Journal of Obstetrics and Gynaecology Research|September 9, 2017
Diagnostic imaging using positron emission tomography for gynecological malignancyHideaki Tsuyoshi, Yoshio YoshidaJournal of Clinical Ultrasound : JCU|April 5, 2013
Color Doppler sonography as an adjunct to repeat uterine evacuation for gestational trophoblastic disease: case reportHideaki Tsuyoshi, Genki Sugita, Tetsuji Kurokawa, et al.The Journal of Obstetrics and Gynaecology Research|July 28, 2020
Hyperthermic intraperitoneal chemotherapy (HIPEC) for gynecological cancerHideaki Tsuyoshi, Daisuke Inoue, Tetsuji Kurokawa, et al.JIMD Reports|January 29, 2014
Fructose-1,6-bisphosphatase deficiency: a case of a successful pregnancy by closely monitoring metabolic controlGenki Sugita, Hideaki Tsuyoshi, Koji Nishijima, et al.The Journal of Obstetrics and Gynaecology Research|January 11, 2012
Diagnosis and management of leiomyosarcoma arising from ovarian vein: case report and literature reviewHideaki Tsuyoshi, Yoshio Yoshida, Tetsuji Kurokawa, et al.Cureus|October 16, 2025
Postpartum Expulsion of an Infected Intramural Uterine Myoma: Rapid Growth in Pregnancy and Definitive Management by Abdominal HysterectomyHitomi Nambu, Aya Shirafuji, Hideaki Tsuyoshi, et al.Clinical Nuclear Medicine|May 4, 2013
18F-fluorothymidine PET is a potential predictive imaging biomarker of the response to gemcitabine-based chemotherapeutic treatment for recurrent ovarian cancer: preliminary results in three patientsHideaki Tsuyoshi, Fumiko Morishita, Makoto Orisaka, et al.Clinical Nuclear Medicine|May 9, 2017
A Novel Diagnostic Strategy Using 16α-[18F]-Fluoro-17-β-Estradiol (18F-FES) PET/MRI to Achieve Complete Resection of Intravenous Leiomyomatosis in Reproductive-Age WomenYoko Chino, Hideaki Tsuyoshi, Tetsuya Tsujikawa, et al.Cancer Imaging : the Official Publication of the International Cancer Imaging Society|October 23, 2020
Diagnostic value of <sup>18</sup>F-FDG PET/MRI for staging in patients with endometrial cancerHideaki Tsuyoshi, Tetsuya Tsujikawa, Shizuka Yamada, et al.Pageof 6